JP1702982S - - Google Patents

Info

Publication number
JP1702982S
JP1702982S JPD2021-11062F JP2021011062F JP1702982S JP 1702982 S JP1702982 S JP 1702982S JP 2021011062 F JP2021011062 F JP 2021011062F JP 1702982 S JP1702982 S JP 1702982S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-11062F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2021-11062F priority Critical patent/JP1702982S/ja
Priority to US29/816,783 priority patent/USD1007705S1/en
Application granted granted Critical
Publication of JP1702982S publication Critical patent/JP1702982S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-11062F 2021-05-25 2021-05-25 Active JP1702982S (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2021-11062F JP1702982S (enExample) 2021-05-25 2021-05-25
US29/816,783 USD1007705S1 (en) 2021-05-25 2021-11-24 Cell storage container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2021-11062F JP1702982S (enExample) 2021-05-25 2021-05-25

Publications (1)

Publication Number Publication Date
JP1702982S true JP1702982S (enExample) 2021-12-27

Family

ID=79645302

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2021-11062F Active JP1702982S (enExample) 2021-05-25 2021-05-25

Country Status (2)

Country Link
US (1) USD1007705S1 (enExample)
JP (1) JP1702982S (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1066728S1 (en) * 2022-09-30 2025-03-11 Maxcyte, Inc. Bag used for sample or collection
TWD226320S (zh) * 2022-12-08 2023-07-01 立克銘白生醫股份有限公司 生物粒子檢測載盤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976923A (en) * 1989-05-12 1990-12-11 Rhode Island Hospital Sample container
US6146875A (en) * 1997-05-02 2000-11-14 Ward; N. Robert Method for culturing microorganisms in prefilled flexible containers
USD421307S (en) * 1998-07-06 2000-02-29 Hikmet Harmanoglu Specimen bag
USD473318S1 (en) * 2001-07-26 2003-04-15 Biocrystal, Ltd. Cell management device
USD548357S1 (en) * 2005-02-11 2007-08-07 Emilio Barbera-Guillem Bioreactor
USD673689S1 (en) * 2011-06-27 2013-01-01 Ge Healthcare Uk Limited Buccal sample collector and container combined
USD717462S1 (en) * 2013-11-04 2014-11-11 Charles River Laboratories, Inc. Cell capture system
JP1552022S (enExample) * 2014-07-04 2019-05-27
USD812741S1 (en) * 2015-08-14 2018-03-13 Mequ A/S Blood transfusion and sampling apparatus
USD824531S1 (en) * 2015-09-28 2018-07-31 Ge Healthcare Uk Limited Biological sample collector device
JP1554534S (enExample) * 2015-09-29 2017-07-10
USD806236S1 (en) * 2016-02-17 2017-12-26 Gary Lin Fluid collection system
US12257209B2 (en) * 2019-07-11 2025-03-25 Howard Beader Recycled two cell container device and methods of manufacturing a recycled two cell container device
USD959017S1 (en) * 2019-09-30 2022-07-26 Tokyo Ohka Kogyo Co., Ltd. Container for cell observation

Also Published As

Publication number Publication date
USD1007705S1 (en) 2023-12-12

Similar Documents

Publication Publication Date Title
JP1702982S (enExample)
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134206A1 (es) Degradantes y usos de los mismos
AR134134A1 (es) Recipiente extraíble para etiquetas de ganado
AR134124A1 (es) Aplicador para la inserción de implantes
AR134126A1 (es) Cubierta de propulsión de energía mareomotriz
AR134114A1 (es) Modificadores covalentes de cisteína de akt1 y sus usos
AR134113A1 (es) Extracción directa de litio usando adsorbente de microingeniería
AR134119A1 (es) Anticuerpos antifactor tisular y conjugados de anticuerpos, composiciones que comprenden anticuerpos antifactor tisular o conjugados de anticuerpos, y métodos para elaborar y utilizar anticuerpos antifactor tisular y conjugados de anticuerpos